IL133138A0 - Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor - Google Patents

Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Info

Publication number: IL133138A0
Authority: IL; Israel
Prior art keywords: thiazolidinedione; diabetes; alpha; treatment; glucosidase inhibitor
Prior art date: 1997-06-18

Application number

IL13313898A

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-18

Filing date

1998-06-15

Publication date

2001-03-19

1997-06-18 Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en

1998-03-27 Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en

1998-06-15 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-03-19 Publication of IL133138A0 publication Critical patent/IL133138A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fodder In General (AREA)
Plural Heterocyclic Compounds (AREA)

IL13313898A 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor IL133138A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9712865.6A GB9712865D0 (en)	1997-06-18	1997-06-18	Novel method of treatment
GBGB9806708.5A GB9806708D0 (en)	1998-03-27	1998-03-27	Novel method
PCT/EP1998/003691 WO1998057635A1 (en)	1997-06-18	1998-06-15	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Publications (1)

Publication Number	Publication Date
IL133138A0 true IL133138A0 (en)	2001-03-19

Family

ID=26311746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13313898A IL133138A0 (en)	1997-06-18	1998-06-15	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Country Status (24)

Country	Link
EP (1)	EP0975343A1 (en)
JP (1)	JP2001523271A (en)
KR (1)	KR20010013845A (en)
CN (1)	CN1274282A (en)
AP (1)	AP9901720A0 (en)
AR (2)	AR013352A1 (en)
AU (1)	AU8799998A (en)
BG (1)	BG103966A (en)
BR (1)	BR9810186A (en)
CA (1)	CA2294134A1 (en)
CO (1)	CO4940453A1 (en)
DZ (1)	DZ2519A1 (en)
EA (1)	EA200000040A1 (en)
IL (1)	IL133138A0 (en)
MA (1)	MA26510A1 (en)
NO (1)	NO996270L (en)
NZ (1)	NZ501345A (en)
OA (1)	OA11631A (en)
PE (1)	PE89199A1 (en)
PL (1)	PL337577A1 (en)
SK (1)	SK179499A3 (en)
TR (1)	TR199903072T2 (en)
UY (1)	UY25051A1 (en)
WO (1)	WO1998057635A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
DE60037602T2 (en)	1999-04-23	2009-01-08	Smithkline Beecham P.L.C., Brentford	Preparation of a polymorphic form of a thiazolidinedione derivative
ATE442148T1 (en)	2001-04-04	2009-09-15	Ortho Mcneil Janssen Pharm	COMBINATION THERAPY USING GLUCOSE ABSORPTION INHIBITORS AND RETINOID X RECEPTOR MODULATORS
JP4590159B2 (en)	2001-04-04	2010-12-01	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	Combination therapy comprising a glucose reabsorption inhibitor and a PPAR modulator
FR2832930A1 (en) *	2001-12-03	2003-06-06	Lipha	PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
JP2004067575A (en) *	2002-08-06	2004-03-04	Yaizu Suisankagaku Industry Co Ltd	Promoter for effect of therapeutic agent for diabetes
CN101121004B (en) *	2006-08-08	2010-07-21	鲁南制药集团股份有限公司	Medicine composition containing insulin intensifier and miglitol
CN101584705B (en) *	2008-05-24	2010-10-27	鲁南制药集团股份有限公司	A kind of pharmaceutical composition for treating diabetes and its complications
CN101584688B (en) *	2008-05-24	2010-11-10	鲁南制药集团股份有限公司	Medicament composition for treating diabetes and complications of diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69219136T2 (en) *	1991-08-26	1997-08-28	Pharmacia & Upjohn Co., Kalamazoo, Mich.	LIQUID FOOD CONTAINING 3-GUANIDINOPROPIONIC ACID
US5917052A (en) *	1994-09-28	1999-06-29	Shaman Pharmaceuticals, Inc.	Hypoglycemic agent from cryptolepis
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes

1998
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 SK SK1794-99A patent/SK179499A3/en unknown
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 CN CN98806319A patent/CN1274282A/en active Pending
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/en unknown
- 1998-06-15 JP JP50375699A patent/JP2001523271A/en not_active Ceased
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/en not_active IP Right Cessation
- 1998-06-15 IL IL13313898A patent/IL133138A0/en unknown
- 1998-06-15 PL PL98337577A patent/PL337577A1/en unknown
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/en not_active Withdrawn
- 1998-06-15 EA EA200000040A patent/EA200000040A1/en unknown
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Ceased
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/en active
- 1998-06-17 AR ARP980102882A patent/AR013352A1/en unknown
- 1998-06-17 MA MA25121A patent/MA26510A1/en unknown
- 1998-06-17 AR ARP980102885A patent/AR014881A1/en unknown
- 1998-06-18 UY UY25051A patent/UY25051A1/en not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/en unknown
- 1998-06-18 PE PE1998000536A patent/PE89199A1/en not_active Application Discontinuation
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
1999
- 1999-12-08 BG BG103966A patent/BG103966A/en unknown
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK179499A3 (en)	2000-11-07
BR9810186A (en)	2000-08-08
TR199903072T2 (en)	2000-07-21
NZ501345A (en)	2001-10-26
WO1998057635A1 (en)	1998-12-23
NO996270D0 (en)	1999-12-17
MA26510A1 (en)	2004-12-20
KR20010013845A (en)	2001-02-26
OA11631A (en)	2004-11-22
AR013352A1 (en)	2000-12-27
EP0975343A1 (en)	2000-02-02
JP2001523271A (en)	2001-11-20
PL337577A1 (en)	2000-08-28
BG103966A (en)	2000-07-31
CA2294134A1 (en)	1998-12-23
EA200000040A1 (en)	2000-08-28
UY25051A1 (en)	2000-09-29
AP9901720A0 (en)	1999-12-31
AU8799998A (en)	1999-01-04
NO996270L (en)	1999-12-17
PE89199A1 (en)	1999-10-23
AR014881A1 (en)	2001-04-11
DZ2519A1 (en)	2003-02-01
CO4940453A1 (en)	2000-07-24
CN1274282A (en)	2000-11-22

Publication	Publication Date	Title
AP9901719A0 (en)	1999-12-31	Treatment of diabetes with thiazolidinedione and metormin
HU9802721D0 (en)	1999-01-28	Method and composition for the treatment and prevention of hyperuricemia
AU5840200A (en)	2001-01-30	Treatment of diabetes and related pathologies
AU6435398A (en)	1998-09-08	Prevention and treatment of hepatocellular cancer
AP9901718A0 (en)	1999-12-31	Treatment of diabetes with rosiglitazone and insulin
IL133138A0 (en)	2001-03-19	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
AP9901717A0 (en)	1999-12-31	Treatment of diabetes with thiazolidinedione and sulphonylurea
AP2000001734A0 (en)	2000-03-31	Treatment of diabetes with thiazolidinedione and sulphonylurea
IL133907A0 (en)	2001-04-30	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
AU7688998A (en)	1998-12-11	Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
HK1025263A (en)	2000-11-10	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
AU4107797A (en)	1998-12-11	Compounds for the treatment and prevention of diabetes
HUP0002668A3 (en)	2001-12-28	Treatment of diabetes with thiazolidinedione and metformin
HUP9903979A3 (en)	2000-05-29	Use of nitric oxidesynthase inhibitors to treat or prevent type ii diabetes
HUP0002669A3 (en)	2001-12-28	Treatment of diabetes with thiazolidinedione and sulphonylurea
IL121656A0 (en)	1998-02-08	Diagnosis prevention and treatment of diabetes
GB9618290D0 (en)	1996-10-16	Treatment of diabetes
ID24355A (en)	2000-07-13	TREATMENT OF MELLITUS DIABETES WITH TIAZOLIDINADION AND ALFA-GLUCOSIDASE INHIBITORS
HK1028198A (en)	2001-02-09	Treatment of diabetes with rosiglitazone and insulin
GB9815149D0 (en)	1998-09-09	Treatment of diabetes
GB9812314D0 (en)	1998-08-05	Treatment of diabetes
GB9700481D0 (en)	1997-02-26	Assay and method of treatment
GB9609897D0 (en)	1996-07-17	Treatment of diabetes
GB9703008D0 (en)	1997-04-02	Treatment of substrates
GB9714804D0 (en)	1997-09-17	Treatment of substrates